60_Day_FRN

Federal Register / Vol. 90, No. 31 / Tuesday, February 18, 2025 / Notices
Matthew Strait,
Deputy Assistant Administrator.

[FR Doc. 2025–02737 Filed 2–14–25; 8:45 am]

Docket: To read or download
comments or other material in the
docket, go to https://
www.regulations.gov. Documents in the
docket are listed in the https://
www.regulations.gov index; however,
some information (e.g., copyrighted
material) is not publicly available to
read or download through the website.
All submissions, including copyrighted
material, are available for inspection
through the OSHA Docket Office.
Contact the OSHA Docket Office at (202)
693–2350 (TTY (877) 889–5627) for
assistance in locating docket
submissions.
Instructions: All submissions must
include the agency name and the OSHA
docket number (OSHA–2012–0031) for
the Information Collection Request
(ICR). OSHA will place comments,
including personal information, in the
public docket, which may be available
online. Therefore, OSHA cautions
interested parties about submitting
personal information such as social
security number and date of birth.
For further information on submitting
comments, see the ‘‘Public
Participation’’ heading in the section of
this notice titled SUPPLEMENTARY

BILLING CODE P

INFORMATION

is notice that on February 4, 2025,
Lonza Tampa, LLC, 4901 West Grace
Street, Tampa, Florida 33607–3805,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):

[FR Doc. 2025–02731 Filed 2–14–25; 8:45 am]
BILLING CODE P

DEPARTMENT OF JUSTICE
Schedule

[Docket No. DEA–1497]

Psilocybin ......................

Importer of Controlled Substances
Application: Lonza Tampa, LLC

The company plans to import drug
code 7437 (Psilocybin) as bulk active
pharmaceutical ingredient and as
finished dosage units for clinical trials,
research, and analytical purposes. No
other activity for this drug code is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.

Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:

Lonza Tampa, LLC has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before March 20, 2025. Such
persons may also file a written request
for a hearing on the application on or
before March 20, 2025.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
SUMMARY:

lotter on DSK11XQN23PROD with NOTICES1

Drug
code

Controlled substance

Drug Enforcement Administration

VerDate Sep<11>2014

17:15 Feb 14, 2025

Jkt 265001

9735

7437

I

Matthew Strait,
Deputy Assistant Administrator.

FOR FURTHER INFORMATION CONTACT:

DEPARTMENT OF LABOR
Occupational Safety and Health
Administration
[Docket No. OSHA–2012–0031]

Seleda Perryman, Directorate of
Standards and Guidance, OSHA, U.S.
Department of Labor, telephone (202)
693–2222.
SUPPLEMENTARY INFORMATION:

I. Background
The Department of Labor, as part of
the continuing effort to reduce
paperwork and respondent (i.e.,
employer) burden, conducts a
preclearance consultation program to
provide the public with an opportunity
AGENCY: Occupational Safety and Health to comment on proposed and
continuing information collection
Administration, Labor.
requirements in accordance with the
ACTION: Request for public comment.
Paperwork Reduction Act of 1995 (PRA)
SUMMARY: OSHA solicits public
(44 U.S.C. 3506(c)(2)(A)). This program
comments concerning the proposal to
ensures that information is in the
extend the Office of Management and
desired format, reporting burden (time
Budget’s (OMB) approval of the
and costs) is minimal, collection
information collection requirements
instruments are clearly understood, and
specified in the 4, 4′-Methylenedianiline OSHA’s estimate of the information
(MDA) in Construction Standard.
collection burden is accurate. The
DATES: Comments must be submitted
Occupational Safety and Health Act of
(postmarked, sent, or received) by April 1970 (OSH Act) (29 U.S.C. 651 et seq.)
21, 2025.
authorizes information collection by
employers as necessary or appropriate
ADDRESSES:
Electronically: You may submit
for enforcement of the OSH Act or for
comments, including attachments,
developing information regarding the
electronically at https://
causes and prevention of occupational
www.regulations.gov, which is the
injuries, illnesses, and incidents (29
Federal eRulemaking Portal. Follow the U.S.C. 657). The OSH Act also requires
instructions online for submitting
that OSHA obtain such information
comments.
with minimum burden upon employers,
4, 4′-Methylenedianiline (MDA) in
Construction Standard; Extension of
the Office of Management and
Budget’s (OMB) Approval of
Information Collection (Paperwork)
Requirements

PO 00000

Frm 00032

Fmt 4703

Sfmt 4703

E:\FR\FM\18FEN1.SGM

18FEN1

lotter on DSK11XQN23PROD with NOTICES1

9736

Federal Register / Vol. 90, No. 31 / Tuesday, February 18, 2025 / Notices

especially those operating small
businesses, and to reduce to the
maximum extent feasible unnecessary
duplication of effort in obtaining
information (29 U.S.C. 657).
The information collection
requirements specified in the 4′, 4′Methylenedianiline in Construction
Standard (the ‘‘MDA Standard’’) (29
CFR 1926.60) protect employees from
the adverse health effects that may
result from their exposure to MDA,
including cancer, liver and skin disease.
The major paperwork requirements
specify that employers must perform
initial, periodic, and additional
exposure monitoring; notify each
worker in writing of their results as soon
as possible but no longer than 5 days
after receiving exposure monitoring
results; and routinely inspect the hands,
face, and forearms of each worker
potentially exposed to MDA for signs of
dermal exposure to MDA. Employers
must also: establish a written
compliance program; institute a
respiratory protection program in
accordance with 29 CFR 1910.134
(OSHA’s Respiratory Protection
Standard); and develop a written
emergency plan for any construction
operation that could have an MDA
emergency (i.e., an unexpected and
potentially hazardous release of MDA).
Employers must label any material or
products containing MDA, including
containers used to store MDAcontaminated protective clothing and
equipment. They also must inform
personnel who launder MDAcontaminated clothing of the
requirement to prevent release of MDA,
and personnel who launder or clean
MDA-contaminated protective clothing
or equipment must receive information
about the potentially harmful effects of
MDA. In addition, employers must post
warning signs at entrances or access
ways to regulated areas, as well as train
workers exposed to MDA at the time of
their initial assignment, and at least
annually thereafter.
Other paperwork provisions of the
MDA Standard require employers to
provide workers with medical
examinations, including initial,
periodic, emergency and follow-up
examinations. As part of the medicalsurveillance program, employers must
ensure that the examining physician
receives specific written information,
and that they obtain from the physician
a written opinion regarding the worker’s
medical results and exposure
limitations.
The MDA Standard also specifies that
employers are to establish and maintain
exposure-monitoring and medicalsurveillance records for each worker

VerDate Sep<11>2014

17:15 Feb 14, 2025

Jkt 265001

who is subject to these requirements,
make any required record available to
OSHA compliance officers and the
National Institute for Occupational
Safety and Health (NIOSH) for
examination and copying, and provide
exposure-monitoring and medicalsurveillance records to workers and
their designated representatives.
II. Special Issues for Comment
OSHA has a particular interest in
comments on the following issues:
• Whether the proposed information
collection requirements are necessary
for the proper performance of the
agency’s functions, including whether
the information is useful;
• The accuracy of OSHA’s estimate of
the burden (time and costs) of the
information collection requirements,
including the validity of the
methodology and assumptions used;
• The quality, utility, and clarity of
the information collected; and
• Ways to minimize the burden on
employers who must comply; for
example, by using automated or other
technological information, and
transmission techniques.
III. Proposed Actions
OSHA is requesting that OMB extend
the approval of the information
collection requirements contained in the
4, 4′-Methylenedianiline (MDA) in
Construction Standard. The agency is
requesting an adjustment decrease in
the burden hours from 1,012 hour to 954
hours, a difference of 58 hours. This
adjustment decrease is due to a decrease
in the number of new employees. Also,
the agency is requesting a decrease in
the capital cost from $152,658 to
$150,486. This reduction in cost is due
to the decrease in the number of
employees receiving medical exams.
OSHA will summarize the comments
submitted in response to this notice and
will include this summary in the
request to OMB to extend the approval
of the information collection
requirements.
Type of Review: Extension of
currently approved collection.
Title: 4, 4′-Methylenedianiline (MDA)
in Construction Standard.
OMB Control Number: 1218–0183.
Affected Public: Business or other forprofits.
Number of Respondents: 330.
Number of Responses: 2,395.
Frequency of Responses: On occasion.
Average Time per Response: Varies.
Estimated Total Burden Hours: 954.
Estimated Cost (Operation and
Maintenance): $150,486.

PO 00000

Frm 00033

Fmt 4703

Sfmt 9990

IV. Public Participation—Submission of
Comments on This Notice and Internet
Access to Comments and Submissions
You may submit comments in
response to this document as follows:
(1) electronically at https://
www.regulations.gov, which is the
Federal eRulemaking Portal; (2) by
facsimile (fax) to the OSHA docket, if
your comments including attachments,
are not longer than 10 pages, at (202)
693–1948. or (3) by hard copy. All
comments, attachments, and other
materials must identify the agency name
and the OSHA docket number for the
ICR (Docket No. OSHA–2012–0031).
You may supplement electronic
submissions by uploading document
files electronically.
Comments and submissions are
posted without change at https://
www.regulations.gov. Therefore, OSHA
cautions commenters about submitting
personal information such as social
security numbers and date of birth.
Although all submissions are listed in
the https://www.regulations.gov index,
some information (e.g., copyrighted
material) is not publicly available to
read or download through this website.
All submissions, including copyrighted
material, are available for inspection
and copying at the OSHA Docket Office.
Information on using the https://
www.regulations.gov website to submit
comments and access the docket is
available at the website’s ‘‘User Tips’’
link.
Contact the OSHA Docket Office for
information about materials not
available through the website, and for
assistance in using the internet to locate
docket submissions.
V. Authority and Signature
Scott C. Ketcham, Deputy Assistant
Secretary of Labor for Occupational
Safety and Health, directed the
preparation of this notice. The authority
for this notice is the Paperwork
Reduction Act of 1995 (44 U.S.C. 3506
et seq.) and Secretary of Labor’s Order
No 8–2020 (85 FR 58393).
Signed at Washington, DC.
Scott C. Ketcham,
Deputy Assistant Secretary of Labor for
Occupational Safety and Health.
[FR Doc. 2025–02704 Filed 2–14–25; 8:45 am]
BILLING CODE 4510–26–P

E:\FR\FM\18FEN1.SGM

18FEN1